Norway looks to ban therapeutic cloning:
This article was originally published in Clinica
Executive Summary
The Norwegian government has drafted a proposal to ban therapeutic cloning as a method to create stem cells for research purposes. But it has also decided to sponsor research into adult stem cells to the tune of NKr1.5 million ($166,500). Health minister Dagfinn Hcentybraten said that while the government considered it important to invest in research that offered a potential hope to seriously ill patients, it was ethically indefensible to use therapeutic cloning to produce stem cells. Research into adult stem cells did not carry the same ethical problems, however, and this is why the government was prepared to offer its support, he said.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.